Treatment of ebv and khsv infection and associated abnormal...

Details Treatment of ebv and khsv infection and associated abnormal... Treatment of ebv and khsv infection and associated abnormal...

C - Chemistry, Metallurgy

12

N

C12N 5/10 (2006.01) A61K 31/513 (2006.01) A61K 31/7072 (2006.01) A61K 35/12 (2006.01) A61K 45/06 (2006.01) A61K 48/00 (2006.01) A61P 31/12 (2006.01) C12N 15/54 (2006.01) C12N 15/85 (2006.01)

Patent

CA 2470938

A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.

L'invention concerne un procédé et une composition de traitement, de prévention et/ou de prophylaxie d'un hôte, et notamment, un être humain, infecté par le virus d'Epstein-Barr (EBV). Ce procédé consiste à administrer une quantité efficace d'un nucléocide uracile 5-substitué ou son sel ou promédicament acceptable sur le plan pharmaceutique, éventuellement dans un diluant ou un excipient acceptables sur le plan pharmaceutique.

Affiliated with

Also associated with

Rating

Treatment of ebv and khsv infection and associated abnormal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of ebv and khsv infection and associated abnormal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ebv and khsv infection and associated abnormal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1846377